The pharmacologist

Ana Belén Elgoyhen, Carla Vanina Rothlin

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Keypoints: 1. One in 10 adults has subjective tinnitus, and for 1 in 100 adults, tinnitus severely affects their quality of life. 2. Despite the significant unmet clinical need for a safe and effective drug targeting tinnitus relief, there is currently not a single FDA-approved drug on the market. 3. Since in some individuals, tinnitus causes irritability, agitation, stress, depression, insomnia, and interferes with normal life, even a drug that produces a small but significant effect would have a huge therapeutic impact. 4. A glimpse of hope is appearing in the near future, as some pharmaceutical industries now have compounds targeting tinnitus in their pipeline. 5. If these compounds finally reach the market, they will set a new era that will revolutionize the treatment of tinnitus.

Original languageEnglish (US)
Title of host publicationTextbook of Tinnitus
PublisherSpringer New York
Pages251-257
Number of pages7
ISBN (Print)9781607611448
DOIs
StatePublished - 2011
Externally publishedYes

Keywords

  • Animal models
  • Drug discovery
  • Lead compounds
  • Phantom sound
  • Tinnitus

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'The pharmacologist'. Together they form a unique fingerprint.

Cite this